News

BEAMER’s Innovative Research on AI-Driven Treatment Adherence Prediction Recognised at International Conference

Published on: 16/08/2023

BEAMER’s Innovative Research on AI-Driven Treatment Adherence Prediction Recognised at International Conference
A conference highlight was the acceptance of BEAMER’s study titled ‘Multi-stakeholder Approach for Designing an AI Model to Predict Treatment Adherence’.

In a remarkable showcase of cutting-edge research and innovation, Beatriz Merino from BEAMER’s Work Package 2 participated in the 25th International Conference on Human-Computer Interaction, hosted at the prestigious AC Bella Sky Hotel and Bella Center.

The conference served as a global platform for sharing advancements in the realm of human-computer interaction. Beatriz represented BEAMER and presented groundbreaking work accomplished within the project.

Her presentation revolved around the outcomes of Work Package 2, a pivotal phase involving the execution of a comprehensive stakeholder strategy. This expertly designed approach aimed to gather essential model requirements, playing a crucial role in shaping the direction of BEAMER’s research. The presentation delved into the intricacies of stakeholder engagement and highlighted results obtained through this collaborative approach.

A conference highlight was the acceptance of BEAMER’s study titled ‘Multi-stakeholder Approach for Designing an AI Model to Predict Treatment Adherence’.

This remarkable achievement underscores BEAMER’s commitment to developing innovative solutions that bridge the gap between technology and healthcare. In this study, semi-structured interviews were conducted with eleven stakeholders from four groups: patients, healthcare professionals, data scientists, and pharmacists. The needs and requirements received were categorised into four key aspects that were translated into requirements and needs: understanding the nature of the drivers, scope, and impact of the problem; identifying data sources; understanding relevant data points; and addressing potential ethical issues.

“We are thrilled to have our work recognized at such a prestigious international forum,” said Beatriz. “This acknowledgement is a testament to the hard work of the entire BEAMER team and the collaborative spirit of our stakeholders.”

Explore the study’s publication here, offering readers an in-depth exploration of the innovative approach and its potential impact on treatment adherence prediction.

NEWS​

Related News

July 2025 ECHAlliance Newsletter sent

28 Jul 2025

Africa Primary Health Care Forum Unites Leaders to Strengthen Health Systems

24 Jul 2025
The inaugural Africa Primary Health Care Forum convenes diverse stakeholders to strengthen PHC systems across Africa. It focuses on lessons from COVID...

Perspectum Proud to Serve UK Biobank: Two Decades of MRI Innovation

24 Jul 2025
Perspectum Helps to Power UK Biobank’s 100,000-MRI Milestone to Transform Global Health. 'Having the LiverMultiScan acquisition protocol in UKBioBank ...

Digital Lifelines Scotland (DLS) programme gains significant momentum

24 Jul 2025
Three big successes for the DHI Digital Lifelines Scotland (DLS) Programme: 1. The independent Evaluation of DLS Phase 2 (2023-2025) has been publishe...

The Economic and Societal Imperative to Invest in Women’s Health – By HLTH

23 Jul 2025
Women's health remains one of healthcare's most under-researched, under-funded and overlooked areas. Despite women making 80% of healthcare decisions ...

Connecting Health Communities in Africa and Launching a New Nigerian Ecosystem

23 Jul 2025
Four key healthcare events in Abuja, Nigeria, highlighted a powerful month of connection, collaboration, and innovation across Africa – with our Commu...

Become a member

Join ECHAlliance to amplify your organisation’s message, grow your networks, connect with innovators and collaborate globally.
 
First name *
Last Name *
Email Address *
Country *
Position *
First name *
Last Name *
Email Address *
Country *
Position *